Author:
Li Zhi-hua,Xiong Qiu-yun,Tu Jian-hong,Gong Yu,Qiu Wei,Zhang Hui-qin,Wei Wen-shong,Hou Yi-Feng,Cui Wei-qi
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology,General Medicine
Reference31 articles.
1. Qiu J, Yang M, Chen W, Gao X, Liu S, Shi S, Xie B. Prevalence and correlates of major depressive disorder in breast cancer survivors in Shanghai, China. Psychooncology. 2011; doi: 10.1002/pon.2075 .
2. McGrogan BT, Gilmartin B, Carney DN, McCann A. Taxanes, microtubules and chemo resistant breast cancer. Biochim Biophys Acta. 2008;1785(2):96–132.
3. Russell P, Hennessy BT, Li J, Carey MS, Bast RC, Freeman T, Venkitaraman AR. Cyclin G1 regulates the outcome of taxane-induced mitotic checkpoint arrest. Oncogene. 2012;31(19):2450–60. doi: 10.1038/onc.2011.431 .
4. Qin YY, Li H, Guo XJ, Ye XF, Wei X, Zhou YH, Zhang XJ, Wang C, Qian W, Lu J, He J. Adjuvant chemotherapy, with or without Taxanes, in Early or operable breast cancer: a meta-analysis of 19 randomized trials with 30698 patients. PLoS ONE. 2011;6(11):e26946.
5. Pusztai L. Markers predicting clinical benefit in breast cancer from microtubule-targeting agents. Ann Oncol. 2007; 18(Suppl 12): xii15–xii20.
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献